Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment

References

• GoralV. Pancreatic cancer: pathogenesis and diagnosis. Asian Pac J Cancer Prev. 2015;16(14):5619–5624. doi:10.7314/APJCP.2015.16.14.561926320426
   PubMedGoogle Scholar
• GaoY, ChenS, SunJ, et al. Traditional Chinese medicine may be further explored as candidate drugs for pancreatic cancer: a review. Phytother Res. 2021;35(2):603–628.32965773
   PubMed Web of Science ®Google Scholar
• KongF, LiuX, ZhouY, et al. Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells. Int J Biochem Cell Biol. 2020;122:105731.32097728
   PubMed Web of Science ®Google Scholar
• HouX, YangL, WangK, et al. HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing the tumor suppressor TGFBR3. Cancer Med. 2021;10(1):350–364. doi:10.1002/cam4.362733280236
   PubMed Web of Science ®Google Scholar
• SungH, FerlayJ, SiegelRL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.33538338
   PubMed Web of Science ®Google Scholar
• McGuiganA, KellyP, TurkingtonRC, JonesC, ColemanHG, McCainRS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24(43):4846–4861. doi:10.3748/wjg.v24.i43.484630487695
   PubMed Web of Science ®Google Scholar
• ZhuH, LiT, DuY, LiM. Pancreatic cancer: challenges and opportunities. BMC Med. 2018;16:214.30463539
   PubMed Web of Science ®Google Scholar
• MizrahiJD, SuranaR, ValleJW, ShroffRT. Pancreatic cancer. Lancet. 2020;395(10242):2008–2020. doi:10.1016/S0140-6736(20)30974-032593337
   PubMed Web of Science ®Google Scholar
• BednarF, SimeoneDM. Recent advances in pancreatic surgery. Curr Opin Gastroenterol. 2014;30(5):518–523. doi:10.1097/MOG.000000000000009625010685
   PubMed Web of Science ®Google Scholar
• BettegowdaC, SausenM, LearyRJ, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224):224ra24–224ra24. doi:10.1126/scitranslmed.3007094
   PubMed Web of Science ®Google Scholar
• YaoC-L, ZhangJ-Q, LiJ-Y, WeiW-L, WuS-F, GuoD-A. Traditional Chinese medicine (TCM) as a source of new anticancer drugs. Nat Prod Rep. 2021. doi:10.1039/D0NP00057D
   Web of Science ®Google Scholar
• KimK-C, YookJ-H, EisenbraunJ, KimB-S, HuberR. Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma – a randomized, controlled pilot study. BMC Complement Altern Med. 2012;12(1). doi:10.1186/1472-6882-12-172
   Web of Science ®Google Scholar
• GavaraskarK, DhulapS, HirwaniRR. Therapeutic and cosmetic applications of evodiamine and its derivatives—a patent review. Fitoterapia. 2015;106:22–35. doi:10.1016/j.fitote.2015.07.01926255828
   PubMed Web of Science ®Google Scholar
• ChenG. Effects of shenfu injection on chemotherapy-induced adverse effects and quality of life in patients with advanced nonsmall cell lung cancer: a systematic review and meta-analysis. J Cancer Res Ther. 2018;14(10):S549–S555. doi:10.4103/0973-1482.18729930249867
   PubMed Web of Science ®Google Scholar
• SuX-L, WangJ-W, CheH, et al. Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer. Chin Med J. 2020;133(24):2987–2997. doi:10.1097/CM9.000000000000114133065603
   PubMed Web of Science ®Google Scholar
• HuangS, PengW, MaoD, et al. Kangai injection, a traditional Chinese medicine, improves efficacy and reduces toxicity of chemotherapy in advanced colorectal cancer patients: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2019;2019:1–15. doi:10.1155/2019/8423037
   Web of Science ®Google Scholar
• MaoD, FengL, HuangS, ZhangS, PengW, ZhangS. Meta-analysis of xihuang pill efficacy when combined with chemotherapy for treatment of breast cancer. Evid Based Complement Alternat Med. 2019;2019:1–14. doi:10.1155/2019/3502460
   Web of Science ®Google Scholar
• WangQ, JiaoL, WangS, et al. Maintenance chemotherapy with Chinese herb medicine formulas vs. with placebo in patients with advanced non-small cell lung cancer after first-line chemotherapy: a multicenter, randomized, double-blind trial. Front Pharmacol. 2018;9:1233. doi:10.3389/fphar.2018.0123330459612
   PubMed Web of Science ®Google Scholar
• GuoW, HuangJ, WangN, et al. Integrating network pharmacology and pharmacological evaluation for deciphering the action mechanism of herbal formula zuojin pill in suppressing hepatocellular carcinoma. Front Pharmacol. 2019;10:1185. doi:10.3389/fphar.2019.0118531649545
   PubMed Web of Science ®Google Scholar
• TongY, WangR, LiuX, et al. Zuojin pill ameliorates chronic atrophic gastritis induced by MNNG through TGF-β1/PI3K/Akt axis. J Ethnopharmacol. 2021;271:113893. doi:10.1016/j.jep.2021.11389333524511
   PubMed Web of Science ®Google Scholar
• PanJ, XuY, SongH, ZhouX, YaoZ, JiG. Extracts of Zuo Jin Wan, a traditional Chinese medicine, phenocopies 5-HTR1D antagonist in attenuating Wnt/beta-catenin signaling in colorectal cancer cells. BMC Complement Altern Med. 2017;17:1–11.28049463
   PubMed Web of Science ®Google Scholar
• WangN, TanH-Y, LiL, YuenM-F, FengY. Berberine and coptidis rhizoma as potential anticancer agents: recent updates and future perspectives. J Ethnopharmacol. 2015;176:35–48. doi:10.1016/j.jep.2015.10.02826494507
   PubMed Web of Science ®Google Scholar
• LamP, CheungF, TanHY, WangN, YuenMF, FengY. Hepatoprotective effects of Chinese medicinal herbs: a focus on anti-inflammatory and anti-oxidative activities. Int J Mol Sci. 2016;17(4):465. doi:10.3390/ijms1704046527043533
   PubMed Web of Science ®Google Scholar
• XuS, PengJ, LiY, et al. Pharmacokinetic comparisons of rutaecarpine and evodiamine after oral administration of Wu-Chu-Yu extracts with different purities to rats. J Ethnopharmacol. 2012;139(2):395–400. doi:10.1016/j.jep.2011.11.02322120018
   PubMed Web of Science ®Google Scholar
• ChouS-T, HsiangC-Y, LoH-Y, et al. Exploration of anti-cancer effects and mechanisms of Zuo-Jin-Wan and its alkaloid components in vitro and in orthotopic HepG2 xenograft immunocompetent mice. BMC Complement Altern Med. 2017;17(1):1–11. doi:10.1186/s12906-017-1586-628049463
   PubMed Web of Science ®Google Scholar
• DuJ, SunY, WangX-F, Lu-Y-Y, ZhouQ-M, SuS-B. Establishment of an experimental breast cancer ZHENG model and curative effect evaluation of Zuo-Jin Wan. Evid Based Complement Alternat Med. 2013;2013:1–6. doi:10.1155/2013/324732
   Web of Science ®Google Scholar
• HuangS, ZhangZ, LiW, et al. Network pharmacology-based prediction and verification of the active ingredients and potential targets of zuojinwan for treating colorectal cancer. Drug Des Devel Ther. 2020;14:2725–2740. doi:10.2147/DDDT.S250991
   PubMed Web of Science ®Google Scholar
• ChenY, KernTS, KiserPD, PalczewskiK. Eyes on systems pharmacology. Pharmacol Res. 2016;114:39–41. doi:10.1016/j.phrs.2016.09.02627720767
   PubMed Web of Science ®Google Scholar
• JingC, SunZ, XieX, et al. Network pharmacology-based identification of the key mechanism of Qinghuo Rougan formula acting on uveitis. Biomed Pharmacother. 2019;120:109381. doi:10.1016/j.biopha.2019.10938131542616
   PubMed Web of Science ®Google Scholar
• LiS, ZhangB. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 2013;11(2):110–120. doi:10.1016/S1875-5364(13)60037-023787177
   PubMed Web of Science ®Google Scholar
• YangS, ZhangJ, YanY, et al. Network pharmacology-based strategy to investigate the pharmacologic mechanisms of atractylodes macrocephala Koidz. for the treatment of chronic gastritis. Front Pharmacol. 2019;10:1629.32063848
   PubMed Web of Science ®Google Scholar
• LuoY, HuJ, LiuY, et al. Invadopodia: a potential target for pancreatic cancer therapy. Crit Rev Oncol Hematol. 2021;159:103236. doi:10.1016/j.critrevonc.2021.10323633482351
   PubMed Web of Science ®Google Scholar
• Martinez-UserosJ, Martin-GalanM, Garcia-FoncillasJ. The match between molecular subtypes, histology and microenvironment of pancreatic cancer and its relevance for chemoresistance. Cancers. 2021;13(2):322. doi:10.3390/cancers1302032233477288
   PubMed Web of Science ®Google Scholar
• NieJ, ZhaoC, DengL, et al. Efficacy of traditional Chinese medicine in treating cancer (review). Biomed Rep. 2016;4(1):3–14. doi:10.3892/br.2015.53726870326
   PubMed Web of Science ®Google Scholar
• XiangY, GuoZ, ZhuP, ChenJ, HuangY. Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science. Cancer Med. 2019;8(5):1958–1975. doi:10.1002/cam4.210830945475
   PubMed Web of Science ®Google Scholar
• LuoH, VongCT, ChenHB, et al. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med. 2019;14(1):58.31892939
   PubMed Web of Science ®Google Scholar
• MoeiniA, CornellaH, VillanuevaA. Emerging signaling pathways in hepatocellular carcinoma. Liver Cancer. 2012;1(2):83–93. doi:10.1159/00034240524159576
   PubMed Web of Science ®Google Scholar
• TanakaS, AriiS. Molecular targeted therapies in hepatocellular carcinoma. Semin Oncol. 2012;39(4):486–492. doi:10.1053/j.seminoncol.2012.05.00522846865
   PubMed Web of Science ®Google Scholar
• MauryaAK, VinayakM. Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line. Mol Biol Rep. 2015;42(9):1419–1429. doi:10.1007/s11033-015-3921-726311153
   PubMed Web of Science ®Google Scholar
• LanCY, ChenSY, KuoCW, LuCC, YenGC. Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells. J Food Drug Anal. 2019;27(4):887–896. doi:10.1016/j.jfda.2019.07.00131590760
   PubMed Web of Science ®Google Scholar
• LiuJ, LuoX, GuoR, JingW, LuH. Cell metabolomics reveals berberine-inhibited pancreatic cancer cell viability and metastasis by regulating citrate metabolism. J Proteome Res. 2020;19(9):3825–3836. doi:10.1021/acs.jproteome.0c0039432692565
   PubMed Web of Science ®Google Scholar
• WangX, LiuY, XuW, et al. Irinotecan and berberine co-delivery liposomes showed improved efficacy and reduced intestinal toxicity compared with Onivyde for pancreatic cancer. Drug Deliv Transl Res. 2021:1–12. doi:10.1007/s13346-020-00884-432337668
   PubMed Web of Science ®Google Scholar
• ShuoWangSZ, SongZ, GongX, et al. Chloroform extract from sophora tonkinensis gagnep. inhibit proliferation, migration, invasion and promote apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway. J Ethnopharmacol. 2021;271:113879. doi:10.1016/j.jep.2021.11387933524509
   PubMed Web of Science ®Google Scholar
• YuX, LiS, PangM, et al. TSPAN7 exerts anti-tumor effects in bladder cancer through the PTEN/PI3K/AKT pathway. Front Oncol. 2021;10: Article 613869. doi:10.3389/fonc.2020.613869
   Web of Science ®Google Scholar
• ZhangM, LinH, GeX, XuY. Overproduced CPSF4 promotes cell proliferation and invasion via PI3K-AKT signaling pathway in oral squamous cell carcinoma. J Oral Maxillofac Surg. 2021;79(5):1177–e1.33535057
   PubMed Web of Science ®Google Scholar
• SeshacharyuluP, PonnusamyMP, HaridasD, JainM, GantiAK, BatraSK. Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16(1):15–31. doi:10.1517/14728222.2011.64861722239438
   PubMed Web of Science ®Google Scholar
• QianW, ChenK, QinT, et al. The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer. J Exp Clin Cancer Res. 2021;40(1):1–9. doi:10.1186/s13046-020-01823-433390177
   PubMed Web of Science ®Google Scholar
• BarmanS, FatimaI, GowrikumarS, SinghAB, BatraSK, DhawanP. MASTL regulates EGFR signaling to promote pancreatic cancer progression. Pancreas. 2020;49(10):1400.
   Web of Science ®Google Scholar